SlideShare a Scribd company logo
1 of 12
Download to read offline
ATS Company Reports: Camlin fine sciences
Company Details
Camlin Fine Sciences is one of the India's leading manufacturers and exporters of food grade
antioxidants and industrial chemicals. The company exited the pharmaceutical business in the
early 2000s and focused more on the specialty niche products business. Camlin Fine Sciences
was demerged in the year 2006 from the Camlin Group and it was a mirror holding with an
investor getting one share of Camlin Fine Sciences and one share of Camlin Limited (Kokuyo
Camlin now).
Camlin Fine Sciences (Camlin Fine) is one of the largest players across the globe in the anti-
oxidant industry. The company has a 40-45 per cent market share in the TBHQ (Tertiary Butyl
Hydroquinone) segment and 70 per cent in the BHA (Butyl Hydroxyl Anisole) segment. It has set
up a wholly owned subsidiary in Brazil, North America and Spain to facilitate better customized
products and services for its American and European clients. It is in the process of setting up
distribution hubs across key geographies to attain faster growth and garner larger market share.
The current market capitalization stands at Rs 865.45 crore. The company has reported a
standalone sales of Rs 108.25 crore and a Net Profit of Rs 6.84 crore for the quarter ended Dec
2014.
Category No. of Shares Percentage
Promoters 48,877,136 51.03
General Public 37,752,829 39.41
Other Companies 7,169,466 7.48
Foreign Promoters 1,172,800 1.22
NBFC and Mutual
Funds
461,820 0.48
Foreign - NRI 249,579 0.26
Foreign Institutions 51,000 0.05
Foreign Industries 50,000 0.05
Financial Institutions 4,500 0.00
Market Cap (Rs Cr) – 865.45
Company P/E – 41.64
Industry P/E – 27.92
Book Value (Rs) – 8.00
Dividend (%) – 35%
EPS (TTM) – 2.17
Dividend Yield (%) – 0.39%
Face Value (Rs) - 1
Share Holding Pattern Financial Details
Industry Forecast
Global chemical market size was estimated at USD 3.9 trillion in 2013 and is expected to grow at 3-4% per
annum over the next 5 years to reach USD 4.7 trillion by 2018. India currently accounts for approximately 3%
of the world chemical market. The Indian chemical and petrochemical industry expanded in 2013 despite
weakness in key export markets and subdued growth in the domestic market. The Indian chemical and
petrochemical industry currently stands at USD 118 Bn and is expected to grow at a CAGR of 8% for the next
five years. The share of this sector in the manufacturing GDP was 15% during 2012-13 and it accounted for
~9% of the total India's exports. Bulk chemicals form the largest sub-segment of Indian chemical industry with
40% market share whereas specialty chemicals with ~19% market share is the fastest growing segment.
The current low per capita consumption across industries and segments and strong growth outlook for the key
end use are the key growth drivers for this industry. To meet the increasing demand either the local production
will have to ramp up or it will be met by imports. In the past decade, India didn't tap its manufacturing potential
to the fullest which led to a surge in the chemical imports. Net imports have grown at ~20% between FY09 and
FY13 where in the same period the domestic output has grown by ~4%.However, going forward, 'Made in
India' could become the next big manufacturing growth story. The Government has set an ambitious plan of
increasing the share of manufacturing in GDP from 16% to 25% by 2022.
Driven by the strong growth outlook for end use industries, the domestic market for specialty chemicals is
expected to grow strongly, buoyed also by the increased adoption of specialty chemicals and their increased
usage in different products categories. Paints coating and construction chemicals, colorants, Active
Pharmaceutical Ingredients (APIs), personal care chemicals and flavors & fragrances are the specific
segments that are expected to do well in the Indian market.
Balance Sheet
Mar '14 Mar '13 Mar '12 Mar '11 Mar '10
Sources Of Funds
Total Share Capital 9.44 9.39 9.36 9.31 5.81
Equity Share Capital 9.44 9.39 9.36 9.31 5.81
Reserves 67.03 51.51 39.89 32.19 27.49
Networth 76.47 60.90 49.25 41.50 33.30
Secured Loans 114.29 91.84 76.69 63.91 40.37
Unsecured Loans 0.00 6.95 6.97 4.31 0.00
Total Debt 114.29 98.79 83.66 68.22 40.37
Total Liabilities 190.76 159.69 132.91 109.72 73.67
Mar '14 Mar '13 Mar '12 Mar '11 Mar '10
Application Of Funds
Gross Block 90.45 92.85 81.69 69.41 60.46
Less: Accum. Depreciation 42.55 38.67 33.27 29.47 23.24
Net Block 47.90 54.18 48.42 39.94 37.22
Capital Work in Progress 2.00 0.76 2.23 3.50 2.07
Investments 3.81 1.33 1.33 1.48 3.40
Inventories 48.84 88.68 48.46 28.98 22.53
Sundry Debtors 91.49 68.48 62.80 40.25 32.96
Cash and Bank Balance 14.37 10.37 7.08 1.42 0.33
Total Current Assets 154.70 167.53 118.34 70.65 55.82
Loans and Advances 78.87 35.97 40.64 35.22 9.65
Fixed Deposits 0.00 0.00 0.00 3.53 2.59
Total CA, Loans & Advances 233.57 203.50 158.98 109.40 68.06
Current Liabilities 86.83 91.66 72.99 40.60 34.25
Provisions 9.69 8.43 5.06 4.01 2.82
Total CL & Provisions 96.52 100.09 78.05 44.61 37.07
Net Current Assets 137.05 103.41 80.93 64.79 30.99
Miscellaneous Expenses 0.00 0.00 0.00 0.00 0.00
Total Assets 190.76 159.68 132.91 109.71 73.68
Contingent Liabilities 145.74 104.86 60.24 29.95 24.24
Book Value (Rs) 16.20 12.97 10.52 44.59 57.28
Profit and Loss Account
Mar '14 Mar '13 Mar '12 Mar '11 Mar '10
Income
Sales Turnover 374.39 313.53 252.06 166.76 126.99
Excise Duty 0.00 0.00 0.00 2.09 2.58
Net Sales 374.39 313.53 252.06 164.67 124.41
Other Income 2.33 2.87 3.56 1.40 1.85
Stock Adjustments -6.27 0.85 5.67 6.03 -1.91
Total Income 370.45 317.25 261.29 172.10 124.35
Expenditure
Raw Materials 231.52 202.38 171.46 113.01 73.44
Power & Fuel Cost 10.40 10.20 10.68 8.71 9.05
Employee Cost 13.98 11.28 9.45 8.11 6.46
Other Manufacturing Expenses 0.00 0.00 0.00 6.13 3.79
Selling and Admin Expenses 0.00 0.00 0.00 12.83 10.64
Miscellaneous Expenses 53.62 44.78 30.56 3.58 3.94
Total Expenses 309.52 268.64 222.15 150.20 107.32
Operating Profit 58.60 45.74 35.58 20.50 15.18
PBDIT 60.93 48.61 39.14 21.90 17.03
Interest 22.40 17.52 16.20 8.00 6.04
PBDT 38.53 31.09 22.94 13.90 10.99
Depreciation 9.32 8.56 6.49 5.46 4.43
Profit Before Tax 29.21 22.53 16.45 8.44 6.56
PBT (Post Extra-ord Items) 29.21 22.53 16.45 8.44 6.56
Tax 10.24 7.77 6.30 1.76 2.30
Reported Net Profit 18.97 14.76 10.14 6.66 4.29
Total Value Addition 78.00 66.26 50.70 37.21 33.87
Equity Dividend 3.32 2.82 2.34 1.86 1.16
Corporate Dividend Tax 0.56 0.48 0.38 0.30 0.20
Per share data (annualised)
Shares in issue (lakhs) 472.04 469.44 467.94 93.06 58.14
Earning Per Share (Rs) 4.02 3.14 2.17 7.16 7.37
Equity Dividend (%) 35.00 30.00 25.00 20.00 20.00
Dividend History
Index and Company Price Movement Comparison
Symbol Value Action
RSI(14) 50.125 Neutral
STOCH(9,6) 79.583 Buy
STOCHRSI(14) 90.436 Overbought
MACD(12,26) -0.130 Sell
ADX(14) 25.986 Buy
Williams %R -5.000 Overbought
CCI(14) 50.8656 Buy
ATR(14) 0.3679 Less Volatility
Highs/Lows(14) 0.0929 Buy
Ultimate Oscillator 55.992 Buy
ROC -0.386 Sell
Bull/Bear Power(13) 0.3140 Buy
Technical Indicators
PBIT – 13.07 v/s 11.75
RoCE – 27.04 v/s 25.07
RoE – 36.19 v/s 25.52
Net Profit Margin – 5.03 v/s 4.66
Return on net worth – 24.80 v/s 24.23
D/ E Ratio – 1.49 v/s 1.62
Interest Cover – 2.30 v/s 2.29
Current Ratio – 0.87 v/s 0.92
Reserves – 67.03 cr v/s 51.51 cr
PAT – 18.97 cr v/s 14.76 cr
Total assets – 190.76 cr v/s 159.08 cr
Net sales – 374.39 cr v/s 313.53 cr
Book Value – 16.20 v/s 12.97
Important Ratios
Days BSE
30 87.15
50 80.03
150 65.29
200 58.31
Simple Moving Average
Recommendations
Buy Camlin Fine Sciences Ltd. at current or
lower market levels
Reasons for the recommendations are :
Healthy financial position and attractive ratios.
Very less competition for the company products.
Increase in demands for junk foods, pharma products and cosmetics will increase in
revenue of the company.
Good performance by company owned subsidiaries will increase profits.
Growth forecast of the this sector of the industry.
Attractive CAGR of the company in recent years.
ATS Company Reports: Camlin fine sciences

More Related Content

What's hot

Finalaya daily market wrap_14 feb 2014
Finalaya daily market wrap_14 feb 2014Finalaya daily market wrap_14 feb 2014
Finalaya daily market wrap_14 feb 2014Investors Empowered
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesIndiaNotes.com
 
Firstcall recommend Jyothy Laboratories, FY15 net profit up 48.7%
Firstcall recommend Jyothy Laboratories, FY15 net profit up 48.7%Firstcall recommend Jyothy Laboratories, FY15 net profit up 48.7%
Firstcall recommend Jyothy Laboratories, FY15 net profit up 48.7%IndiaNotes.com
 
Sanofi India: Q2CY14 net rises 12.30%, maintain buy
 Sanofi India: Q2CY14 net rises 12.30%, maintain buy Sanofi India: Q2CY14 net rises 12.30%, maintain buy
Sanofi India: Q2CY14 net rises 12.30%, maintain buyIndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
Rupee depreciation article july 2013
Rupee depreciation article july 2013Rupee depreciation article july 2013
Rupee depreciation article july 2013Ajey Bhangale
 
Coral Laboratories Q4FY15: Surplus scenario likely to continue for next three...
Coral Laboratories Q4FY15: Surplus scenario likely to continue for next three...Coral Laboratories Q4FY15: Surplus scenario likely to continue for next three...
Coral Laboratories Q4FY15: Surplus scenario likely to continue for next three...IndiaNotes.com
 
ICI ratio analyis
ICI ratio analyis ICI ratio analyis
ICI ratio analyis usmanali4285
 
P&g presentation
P&g presentationP&g presentation
P&g presentationElisa Reyes
 

What's hot (20)

Finalaya daily wrap_24oct2013
Finalaya daily wrap_24oct2013Finalaya daily wrap_24oct2013
Finalaya daily wrap_24oct2013
 
Finalaya daily market wrap_14 feb 2014
Finalaya daily market wrap_14 feb 2014Finalaya daily market wrap_14 feb 2014
Finalaya daily market wrap_14 feb 2014
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
 
Et news 18th sep
Et news 18th sepEt news 18th sep
Et news 18th sep
 
Finalaya daily wrap_12dec2013
Finalaya daily wrap_12dec2013Finalaya daily wrap_12dec2013
Finalaya daily wrap_12dec2013
 
ATS Company Reports: Lloyd eletricals
ATS Company Reports: Lloyd eletricalsATS Company Reports: Lloyd eletricals
ATS Company Reports: Lloyd eletricals
 
Firstcall recommend Jyothy Laboratories, FY15 net profit up 48.7%
Firstcall recommend Jyothy Laboratories, FY15 net profit up 48.7%Firstcall recommend Jyothy Laboratories, FY15 net profit up 48.7%
Firstcall recommend Jyothy Laboratories, FY15 net profit up 48.7%
 
Finalaya daily wrap_17oct2013
Finalaya daily wrap_17oct2013Finalaya daily wrap_17oct2013
Finalaya daily wrap_17oct2013
 
ATS Company Reports: Ccl products india ltd.
ATS Company Reports: Ccl products india ltd.ATS Company Reports: Ccl products india ltd.
ATS Company Reports: Ccl products india ltd.
 
Sanofi India: Q2CY14 net rises 12.30%, maintain buy
 Sanofi India: Q2CY14 net rises 12.30%, maintain buy Sanofi India: Q2CY14 net rises 12.30%, maintain buy
Sanofi India: Q2CY14 net rises 12.30%, maintain buy
 
ATS Company Reports: Tribhovandas Bhimji Zaveri Ltd.
ATS Company Reports: Tribhovandas Bhimji Zaveri Ltd.ATS Company Reports: Tribhovandas Bhimji Zaveri Ltd.
ATS Company Reports: Tribhovandas Bhimji Zaveri Ltd.
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
Rupee depreciation article july 2013
Rupee depreciation article july 2013Rupee depreciation article july 2013
Rupee depreciation article july 2013
 
Coral Laboratories Q4FY15: Surplus scenario likely to continue for next three...
Coral Laboratories Q4FY15: Surplus scenario likely to continue for next three...Coral Laboratories Q4FY15: Surplus scenario likely to continue for next three...
Coral Laboratories Q4FY15: Surplus scenario likely to continue for next three...
 
Finalaya daily wrap_03mar2014
Finalaya daily wrap_03mar2014Finalaya daily wrap_03mar2014
Finalaya daily wrap_03mar2014
 
Egypt Book - June 2016
Egypt Book - June 2016Egypt Book - June 2016
Egypt Book - June 2016
 
Finalaya daily wrap_09aug2012
Finalaya daily wrap_09aug2012Finalaya daily wrap_09aug2012
Finalaya daily wrap_09aug2012
 
ICI ratio analyis
ICI ratio analyis ICI ratio analyis
ICI ratio analyis
 
Finalaya daily wrap_07 jan 2014
Finalaya daily wrap_07 jan 2014Finalaya daily wrap_07 jan 2014
Finalaya daily wrap_07 jan 2014
 
P&g presentation
P&g presentationP&g presentation
P&g presentation
 

Viewers also liked

IB1412268_MEGHA PARDHI
IB1412268_MEGHA PARDHIIB1412268_MEGHA PARDHI
IB1412268_MEGHA PARDHIMegha Pardhi
 
Disney consumer products, marketing nutrition to children
Disney consumer products, marketing nutrition to childrenDisney consumer products, marketing nutrition to children
Disney consumer products, marketing nutrition to childrenSameer Mathur
 
The State of Sales & Marketing at the 50 Fastest-Growing B2B Companies
The State of Sales & Marketing at the 50 Fastest-Growing B2B CompaniesThe State of Sales & Marketing at the 50 Fastest-Growing B2B Companies
The State of Sales & Marketing at the 50 Fastest-Growing B2B CompaniesMattermark
 
What Makes Great Infographics
What Makes Great InfographicsWhat Makes Great Infographics
What Makes Great InfographicsSlideShare
 
Masters of SlideShare
Masters of SlideShareMasters of SlideShare
Masters of SlideShareKapost
 
10 Ways to Win at SlideShare SEO & Presentation Optimization
10 Ways to Win at SlideShare SEO & Presentation Optimization10 Ways to Win at SlideShare SEO & Presentation Optimization
10 Ways to Win at SlideShare SEO & Presentation OptimizationOneupweb
 
STOP! VIEW THIS! 10-Step Checklist When Uploading to Slideshare
STOP! VIEW THIS! 10-Step Checklist When Uploading to SlideshareSTOP! VIEW THIS! 10-Step Checklist When Uploading to Slideshare
STOP! VIEW THIS! 10-Step Checklist When Uploading to SlideshareEmpowered Presentations
 
How To Get More From SlideShare - Super-Simple Tips For Content Marketing
How To Get More From SlideShare - Super-Simple Tips For Content MarketingHow To Get More From SlideShare - Super-Simple Tips For Content Marketing
How To Get More From SlideShare - Super-Simple Tips For Content MarketingContent Marketing Institute
 
How to Make Awesome SlideShares: Tips & Tricks
How to Make Awesome SlideShares: Tips & TricksHow to Make Awesome SlideShares: Tips & Tricks
How to Make Awesome SlideShares: Tips & TricksSlideShare
 
Getting Started With SlideShare
Getting Started With SlideShareGetting Started With SlideShare
Getting Started With SlideShareSlideShare
 

Viewers also liked (13)

IB1412268_MEGHA PARDHI
IB1412268_MEGHA PARDHIIB1412268_MEGHA PARDHI
IB1412268_MEGHA PARDHI
 
Disney consumer products, marketing nutrition to children
Disney consumer products, marketing nutrition to childrenDisney consumer products, marketing nutrition to children
Disney consumer products, marketing nutrition to children
 
Camlin
CamlinCamlin
Camlin
 
Camlin
CamlinCamlin
Camlin
 
The State of Sales & Marketing at the 50 Fastest-Growing B2B Companies
The State of Sales & Marketing at the 50 Fastest-Growing B2B CompaniesThe State of Sales & Marketing at the 50 Fastest-Growing B2B Companies
The State of Sales & Marketing at the 50 Fastest-Growing B2B Companies
 
What Makes Great Infographics
What Makes Great InfographicsWhat Makes Great Infographics
What Makes Great Infographics
 
You Suck At PowerPoint!
You Suck At PowerPoint!You Suck At PowerPoint!
You Suck At PowerPoint!
 
Masters of SlideShare
Masters of SlideShareMasters of SlideShare
Masters of SlideShare
 
10 Ways to Win at SlideShare SEO & Presentation Optimization
10 Ways to Win at SlideShare SEO & Presentation Optimization10 Ways to Win at SlideShare SEO & Presentation Optimization
10 Ways to Win at SlideShare SEO & Presentation Optimization
 
STOP! VIEW THIS! 10-Step Checklist When Uploading to Slideshare
STOP! VIEW THIS! 10-Step Checklist When Uploading to SlideshareSTOP! VIEW THIS! 10-Step Checklist When Uploading to Slideshare
STOP! VIEW THIS! 10-Step Checklist When Uploading to Slideshare
 
How To Get More From SlideShare - Super-Simple Tips For Content Marketing
How To Get More From SlideShare - Super-Simple Tips For Content MarketingHow To Get More From SlideShare - Super-Simple Tips For Content Marketing
How To Get More From SlideShare - Super-Simple Tips For Content Marketing
 
How to Make Awesome SlideShares: Tips & Tricks
How to Make Awesome SlideShares: Tips & TricksHow to Make Awesome SlideShares: Tips & Tricks
How to Make Awesome SlideShares: Tips & Tricks
 
Getting Started With SlideShare
Getting Started With SlideShareGetting Started With SlideShare
Getting Started With SlideShare
 

Similar to ATS Company Reports: Camlin fine sciences

Brooks Laboratories FY15: Net profits up 31% y/y; Buy
Brooks Laboratories FY15: Net profits up 31% y/y; BuyBrooks Laboratories FY15: Net profits up 31% y/y; Buy
Brooks Laboratories FY15: Net profits up 31% y/y; BuyIndiaNotes.com
 
Indian chemical industry to reach a size of $350 bn by 2021; Buy Vinyl Chemicals
Indian chemical industry to reach a size of $350 bn by 2021; Buy Vinyl ChemicalsIndian chemical industry to reach a size of $350 bn by 2021; Buy Vinyl Chemicals
Indian chemical industry to reach a size of $350 bn by 2021; Buy Vinyl ChemicalsIndiaNotes.com
 
Divi's Lab Q4FY15: Net profit up 18.57% y/y to INR2,289.10m, Firstcall recomm...
Divi's Lab Q4FY15: Net profit up 18.57% y/y to INR2,289.10m, Firstcall recomm...Divi's Lab Q4FY15: Net profit up 18.57% y/y to INR2,289.10m, Firstcall recomm...
Divi's Lab Q4FY15: Net profit up 18.57% y/y to INR2,289.10m, Firstcall recomm...IndiaNotes.com
 
Dhanuka Agritech's FY15 net profit up 14%; Buy
Dhanuka Agritech's FY15 net profit up 14%; BuyDhanuka Agritech's FY15 net profit up 14%; Buy
Dhanuka Agritech's FY15 net profit up 14%; BuyIndiaNotes.com
 
Shilpa Medicare: Buy for medium to long term investment
Shilpa Medicare: Buy for medium to long term investmentShilpa Medicare: Buy for medium to long term investment
Shilpa Medicare: Buy for medium to long term investmentIndiaNotes.com
 
Firstcall recommends an ethnic Indian foods scrip
Firstcall recommends an ethnic Indian foods scripFirstcall recommends an ethnic Indian foods scrip
Firstcall recommends an ethnic Indian foods scripIndiaNotes.com
 
Fce deepak nitrite_28jul15
Fce deepak nitrite_28jul15Fce deepak nitrite_28jul15
Fce deepak nitrite_28jul15IndiaNotes.com
 
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'IndiaNotes.com
 
Bayer CropScience: Recommends a dividend of Rs 5.50 for FY14, buy
Bayer CropScience: Recommends a dividend of Rs 5.50 for FY14, buyBayer CropScience: Recommends a dividend of Rs 5.50 for FY14, buy
Bayer CropScience: Recommends a dividend of Rs 5.50 for FY14, buyIndiaNotes.com
 
Buy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 years
Buy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 yearsBuy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 years
Buy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 yearsIndiaNotes.com
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...IndiaNotes.com
 
Firstcall metroglobal limited_13jul15
Firstcall metroglobal limited_13jul15Firstcall metroglobal limited_13jul15
Firstcall metroglobal limited_13jul15IndiaNotes.com
 
HUL Fundamental & SWOT Analysis
HUL Fundamental & SWOT Analysis HUL Fundamental & SWOT Analysis
HUL Fundamental & SWOT Analysis Tapish Pandey
 

Similar to ATS Company Reports: Camlin fine sciences (20)

ATS Company Reports: Adi finechem ltd.
ATS Company Reports:  Adi finechem ltd.ATS Company Reports:  Adi finechem ltd.
ATS Company Reports: Adi finechem ltd.
 
Brooks Laboratories FY15: Net profits up 31% y/y; Buy
Brooks Laboratories FY15: Net profits up 31% y/y; BuyBrooks Laboratories FY15: Net profits up 31% y/y; Buy
Brooks Laboratories FY15: Net profits up 31% y/y; Buy
 
Indian chemical industry to reach a size of $350 bn by 2021; Buy Vinyl Chemicals
Indian chemical industry to reach a size of $350 bn by 2021; Buy Vinyl ChemicalsIndian chemical industry to reach a size of $350 bn by 2021; Buy Vinyl Chemicals
Indian chemical industry to reach a size of $350 bn by 2021; Buy Vinyl Chemicals
 
ATS Company Reports: Rcf ltd.
ATS Company Reports: Rcf ltd.ATS Company Reports: Rcf ltd.
ATS Company Reports: Rcf ltd.
 
ATS Company Reports: Mayur
ATS Company Reports: MayurATS Company Reports: Mayur
ATS Company Reports: Mayur
 
ATS Company Reports: Alembic pharma ltd.
ATS Company Reports: Alembic pharma ltd.ATS Company Reports: Alembic pharma ltd.
ATS Company Reports: Alembic pharma ltd.
 
Divi's Lab Q4FY15: Net profit up 18.57% y/y to INR2,289.10m, Firstcall recomm...
Divi's Lab Q4FY15: Net profit up 18.57% y/y to INR2,289.10m, Firstcall recomm...Divi's Lab Q4FY15: Net profit up 18.57% y/y to INR2,289.10m, Firstcall recomm...
Divi's Lab Q4FY15: Net profit up 18.57% y/y to INR2,289.10m, Firstcall recomm...
 
ATS Company Reports: Pheonix lamps
ATS Company Reports: Pheonix lampsATS Company Reports: Pheonix lamps
ATS Company Reports: Pheonix lamps
 
Dhanuka Agritech's FY15 net profit up 14%; Buy
Dhanuka Agritech's FY15 net profit up 14%; BuyDhanuka Agritech's FY15 net profit up 14%; Buy
Dhanuka Agritech's FY15 net profit up 14%; Buy
 
Shilpa Medicare: Buy for medium to long term investment
Shilpa Medicare: Buy for medium to long term investmentShilpa Medicare: Buy for medium to long term investment
Shilpa Medicare: Buy for medium to long term investment
 
Firstcall recommends an ethnic Indian foods scrip
Firstcall recommends an ethnic Indian foods scripFirstcall recommends an ethnic Indian foods scrip
Firstcall recommends an ethnic Indian foods scrip
 
Fce deepak nitrite_28jul15
Fce deepak nitrite_28jul15Fce deepak nitrite_28jul15
Fce deepak nitrite_28jul15
 
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'
 
ATS Company Reports: Dabur ltd.
ATS Company Reports: Dabur ltd.ATS Company Reports: Dabur ltd.
ATS Company Reports: Dabur ltd.
 
Bayer CropScience: Recommends a dividend of Rs 5.50 for FY14, buy
Bayer CropScience: Recommends a dividend of Rs 5.50 for FY14, buyBayer CropScience: Recommends a dividend of Rs 5.50 for FY14, buy
Bayer CropScience: Recommends a dividend of Rs 5.50 for FY14, buy
 
Buy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 years
Buy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 yearsBuy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 years
Buy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 years
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
 
Firstcall metroglobal limited_13jul15
Firstcall metroglobal limited_13jul15Firstcall metroglobal limited_13jul15
Firstcall metroglobal limited_13jul15
 
ATS Company Reports: Nrb bearing
ATS Company Reports: Nrb bearingATS Company Reports: Nrb bearing
ATS Company Reports: Nrb bearing
 
HUL Fundamental & SWOT Analysis
HUL Fundamental & SWOT Analysis HUL Fundamental & SWOT Analysis
HUL Fundamental & SWOT Analysis
 

More from Aditya Trading Solutions Pvt Ltd

More from Aditya Trading Solutions Pvt Ltd (20)

Subsidies, Indian Scenario and Road Ahead
 Subsidies, Indian Scenario and Road Ahead  Subsidies, Indian Scenario and Road Ahead
Subsidies, Indian Scenario and Road Ahead
 
ATS Company Reports: Ambuja cements ltd.
ATS Company Reports: Ambuja cements ltd.ATS Company Reports: Ambuja cements ltd.
ATS Company Reports: Ambuja cements ltd.
 
ATS Company Reports: Finolex cables ltd
ATS Company Reports: Finolex cables ltdATS Company Reports: Finolex cables ltd
ATS Company Reports: Finolex cables ltd
 
ATS Company Reports: Aries agro ltd.
ATS Company Reports: Aries agro ltd.ATS Company Reports: Aries agro ltd.
ATS Company Reports: Aries agro ltd.
 
ATS Company Reports: Acrysil ltd.
ATS Company Reports: Acrysil ltd.ATS Company Reports: Acrysil ltd.
ATS Company Reports: Acrysil ltd.
 
ATS Company Reports: Nandan denim ltd.
ATS Company Reports: Nandan denim ltd.ATS Company Reports: Nandan denim ltd.
ATS Company Reports: Nandan denim ltd.
 
ATS Company Reports: Biocon ltd.
ATS Company Reports: Biocon ltd.ATS Company Reports: Biocon ltd.
ATS Company Reports: Biocon ltd.
 
Escorts ltd.
Escorts ltd.Escorts ltd.
Escorts ltd.
 
ATS Company Reports: Dcb bank
ATS Company Reports: Dcb bankATS Company Reports: Dcb bank
ATS Company Reports: Dcb bank
 
ATS Company Reports: Elgi equipments ltd.
ATS Company Reports: Elgi equipments ltd.ATS Company Reports: Elgi equipments ltd.
ATS Company Reports: Elgi equipments ltd.
 
ATS Company Reports: Puravankara projects ltd.
ATS Company Reports: Puravankara projects ltd.ATS Company Reports: Puravankara projects ltd.
ATS Company Reports: Puravankara projects ltd.
 
ATS Company Reports: Grauer weil (india) ltd.
ATS Company Reports: Grauer weil (india) ltd.ATS Company Reports: Grauer weil (india) ltd.
ATS Company Reports: Grauer weil (india) ltd.
 
ATS Company Reports: Sundram fastners ltd.
ATS Company Reports: Sundram fastners ltd.ATS Company Reports: Sundram fastners ltd.
ATS Company Reports: Sundram fastners ltd.
 
ATS Company Reports: Greenply industries ltd.
ATS Company Reports: Greenply industries ltd.ATS Company Reports: Greenply industries ltd.
ATS Company Reports: Greenply industries ltd.
 
ATS Company Reports: Electro steel castings ltd.
ATS Company Reports: Electro steel castings ltd.ATS Company Reports: Electro steel castings ltd.
ATS Company Reports: Electro steel castings ltd.
 
ATS Company Reports: Vakrangee Ltd
ATS Company Reports: Vakrangee LtdATS Company Reports: Vakrangee Ltd
ATS Company Reports: Vakrangee Ltd
 
ATS Company Reports: Unichem lab
ATS Company Reports: Unichem labATS Company Reports: Unichem lab
ATS Company Reports: Unichem lab
 
ATS Company Reports: Triveni turbines
ATS Company Reports: Triveni turbinesATS Company Reports: Triveni turbines
ATS Company Reports: Triveni turbines
 
ATS Company Reports: Suven life sciences
ATS Company Reports: Suven life sciencesATS Company Reports: Suven life sciences
ATS Company Reports: Suven life sciences
 
ATS Company Reports: Sonata
ATS Company Reports: SonataATS Company Reports: Sonata
ATS Company Reports: Sonata
 

Recently uploaded

The CBR Covered Bond Investor Roundtable 2024
The CBR Covered Bond Investor Roundtable 2024The CBR Covered Bond Investor Roundtable 2024
The CBR Covered Bond Investor Roundtable 2024Neil Day
 
Hungarys economy made by Robert Miklos
Hungarys economy   made by Robert MiklosHungarys economy   made by Robert Miklos
Hungarys economy made by Robert Miklosbeduinpower135
 
ACADEMIC BANK OF CREDIT: A WORLDWIDE VIEWPOINT
ACADEMIC BANK OF CREDIT: A WORLDWIDE VIEWPOINTACADEMIC BANK OF CREDIT: A WORLDWIDE VIEWPOINT
ACADEMIC BANK OF CREDIT: A WORLDWIDE VIEWPOINTindexPub
 
The Power Laws of Bitcoin: How can an S-curve be a power law?
The Power Laws of Bitcoin: How can an S-curve be a power law?The Power Laws of Bitcoin: How can an S-curve be a power law?
The Power Laws of Bitcoin: How can an S-curve be a power law?Stephen Perrenod
 
20240314 Calibre March 2024 Investor Presentation (FINAL).pdf
20240314 Calibre March 2024 Investor Presentation (FINAL).pdf20240314 Calibre March 2024 Investor Presentation (FINAL).pdf
20240314 Calibre March 2024 Investor Presentation (FINAL).pdfAdnet Communications
 
India Economic Survey Complete for the year of 2022 to 2023
India Economic Survey Complete for the year of 2022 to 2023India Economic Survey Complete for the year of 2022 to 2023
India Economic Survey Complete for the year of 2022 to 2023SkillCircle
 
LIC PRIVATISATION its a bane or boon.pptx
LIC PRIVATISATION its a bane or boon.pptxLIC PRIVATISATION its a bane or boon.pptx
LIC PRIVATISATION its a bane or boon.pptxsonamyadav7097
 
Contracts with Interdependent Preferences
Contracts with Interdependent PreferencesContracts with Interdependent Preferences
Contracts with Interdependent PreferencesGRAPE
 
ACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTES
ACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTESACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTES
ACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTESKumarJayaraman3
 
The unequal battle of inflation and the appropriate sustainable solution | Eu...
The unequal battle of inflation and the appropriate sustainable solution | Eu...The unequal battle of inflation and the appropriate sustainable solution | Eu...
The unequal battle of inflation and the appropriate sustainable solution | Eu...Antonis Zairis
 
RWA Report 2024: Rise of Real-World Assets in Crypto | CoinGecko
RWA Report 2024: Rise of Real-World Assets in Crypto | CoinGeckoRWA Report 2024: Rise of Real-World Assets in Crypto | CoinGecko
RWA Report 2024: Rise of Real-World Assets in Crypto | CoinGeckoCoinGecko
 
CLMV-Outlook-March-2024-ENG-20240327.pdf
CLMV-Outlook-March-2024-ENG-20240327.pdfCLMV-Outlook-March-2024-ENG-20240327.pdf
CLMV-Outlook-March-2024-ENG-20240327.pdfSCBEICSCB
 
Monthly Market Risk Update: March 2024 [SlideShare]
Monthly Market Risk Update: March 2024 [SlideShare]Monthly Market Risk Update: March 2024 [SlideShare]
Monthly Market Risk Update: March 2024 [SlideShare]Commonwealth
 
Stock Market Brief Deck for 3/22/2024.pdf
Stock Market Brief Deck for 3/22/2024.pdfStock Market Brief Deck for 3/22/2024.pdf
Stock Market Brief Deck for 3/22/2024.pdfMichael Silva
 
Sarlat Advisory - Corporate Brochure - 2024
Sarlat Advisory - Corporate Brochure - 2024Sarlat Advisory - Corporate Brochure - 2024
Sarlat Advisory - Corporate Brochure - 2024Guillaume Ⓥ Sarlat
 
Solution manual for Intermediate Accounting, 11th Edition by David Spiceland...
Solution manual for  Intermediate Accounting, 11th Edition by David Spiceland...Solution manual for  Intermediate Accounting, 11th Edition by David Spiceland...
Solution manual for Intermediate Accounting, 11th Edition by David Spiceland...mwangimwangi222
 

Recently uploaded (20)

The CBR Covered Bond Investor Roundtable 2024
The CBR Covered Bond Investor Roundtable 2024The CBR Covered Bond Investor Roundtable 2024
The CBR Covered Bond Investor Roundtable 2024
 
Hungarys economy made by Robert Miklos
Hungarys economy   made by Robert MiklosHungarys economy   made by Robert Miklos
Hungarys economy made by Robert Miklos
 
ACADEMIC BANK OF CREDIT: A WORLDWIDE VIEWPOINT
ACADEMIC BANK OF CREDIT: A WORLDWIDE VIEWPOINTACADEMIC BANK OF CREDIT: A WORLDWIDE VIEWPOINT
ACADEMIC BANK OF CREDIT: A WORLDWIDE VIEWPOINT
 
The Power Laws of Bitcoin: How can an S-curve be a power law?
The Power Laws of Bitcoin: How can an S-curve be a power law?The Power Laws of Bitcoin: How can an S-curve be a power law?
The Power Laws of Bitcoin: How can an S-curve be a power law?
 
20240314 Calibre March 2024 Investor Presentation (FINAL).pdf
20240314 Calibre March 2024 Investor Presentation (FINAL).pdf20240314 Calibre March 2024 Investor Presentation (FINAL).pdf
20240314 Calibre March 2024 Investor Presentation (FINAL).pdf
 
E-levy and Merchant Payment Exemption in Ghana
E-levy and Merchant Payment Exemption in GhanaE-levy and Merchant Payment Exemption in Ghana
E-levy and Merchant Payment Exemption in Ghana
 
India Economic Survey Complete for the year of 2022 to 2023
India Economic Survey Complete for the year of 2022 to 2023India Economic Survey Complete for the year of 2022 to 2023
India Economic Survey Complete for the year of 2022 to 2023
 
LIC PRIVATISATION its a bane or boon.pptx
LIC PRIVATISATION its a bane or boon.pptxLIC PRIVATISATION its a bane or boon.pptx
LIC PRIVATISATION its a bane or boon.pptx
 
Digital Financial Services Taxation in Africa
Digital Financial Services Taxation in AfricaDigital Financial Services Taxation in Africa
Digital Financial Services Taxation in Africa
 
Contracts with Interdependent Preferences
Contracts with Interdependent PreferencesContracts with Interdependent Preferences
Contracts with Interdependent Preferences
 
ACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTES
ACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTESACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTES
ACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTES
 
The unequal battle of inflation and the appropriate sustainable solution | Eu...
The unequal battle of inflation and the appropriate sustainable solution | Eu...The unequal battle of inflation and the appropriate sustainable solution | Eu...
The unequal battle of inflation and the appropriate sustainable solution | Eu...
 
RWA Report 2024: Rise of Real-World Assets in Crypto | CoinGecko
RWA Report 2024: Rise of Real-World Assets in Crypto | CoinGeckoRWA Report 2024: Rise of Real-World Assets in Crypto | CoinGecko
RWA Report 2024: Rise of Real-World Assets in Crypto | CoinGecko
 
Commercial Bank Economic Capsule - March 2024
Commercial Bank Economic Capsule - March 2024Commercial Bank Economic Capsule - March 2024
Commercial Bank Economic Capsule - March 2024
 
Mobile Money Taxes: Knowledge, Perceptions and Politics: The Case of Ghana
Mobile Money Taxes: Knowledge, Perceptions and Politics: The Case of GhanaMobile Money Taxes: Knowledge, Perceptions and Politics: The Case of Ghana
Mobile Money Taxes: Knowledge, Perceptions and Politics: The Case of Ghana
 
CLMV-Outlook-March-2024-ENG-20240327.pdf
CLMV-Outlook-March-2024-ENG-20240327.pdfCLMV-Outlook-March-2024-ENG-20240327.pdf
CLMV-Outlook-March-2024-ENG-20240327.pdf
 
Monthly Market Risk Update: March 2024 [SlideShare]
Monthly Market Risk Update: March 2024 [SlideShare]Monthly Market Risk Update: March 2024 [SlideShare]
Monthly Market Risk Update: March 2024 [SlideShare]
 
Stock Market Brief Deck for 3/22/2024.pdf
Stock Market Brief Deck for 3/22/2024.pdfStock Market Brief Deck for 3/22/2024.pdf
Stock Market Brief Deck for 3/22/2024.pdf
 
Sarlat Advisory - Corporate Brochure - 2024
Sarlat Advisory - Corporate Brochure - 2024Sarlat Advisory - Corporate Brochure - 2024
Sarlat Advisory - Corporate Brochure - 2024
 
Solution manual for Intermediate Accounting, 11th Edition by David Spiceland...
Solution manual for  Intermediate Accounting, 11th Edition by David Spiceland...Solution manual for  Intermediate Accounting, 11th Edition by David Spiceland...
Solution manual for Intermediate Accounting, 11th Edition by David Spiceland...
 

ATS Company Reports: Camlin fine sciences

  • 2. Company Details Camlin Fine Sciences is one of the India's leading manufacturers and exporters of food grade antioxidants and industrial chemicals. The company exited the pharmaceutical business in the early 2000s and focused more on the specialty niche products business. Camlin Fine Sciences was demerged in the year 2006 from the Camlin Group and it was a mirror holding with an investor getting one share of Camlin Fine Sciences and one share of Camlin Limited (Kokuyo Camlin now). Camlin Fine Sciences (Camlin Fine) is one of the largest players across the globe in the anti- oxidant industry. The company has a 40-45 per cent market share in the TBHQ (Tertiary Butyl Hydroquinone) segment and 70 per cent in the BHA (Butyl Hydroxyl Anisole) segment. It has set up a wholly owned subsidiary in Brazil, North America and Spain to facilitate better customized products and services for its American and European clients. It is in the process of setting up distribution hubs across key geographies to attain faster growth and garner larger market share. The current market capitalization stands at Rs 865.45 crore. The company has reported a standalone sales of Rs 108.25 crore and a Net Profit of Rs 6.84 crore for the quarter ended Dec 2014.
  • 3. Category No. of Shares Percentage Promoters 48,877,136 51.03 General Public 37,752,829 39.41 Other Companies 7,169,466 7.48 Foreign Promoters 1,172,800 1.22 NBFC and Mutual Funds 461,820 0.48 Foreign - NRI 249,579 0.26 Foreign Institutions 51,000 0.05 Foreign Industries 50,000 0.05 Financial Institutions 4,500 0.00 Market Cap (Rs Cr) – 865.45 Company P/E – 41.64 Industry P/E – 27.92 Book Value (Rs) – 8.00 Dividend (%) – 35% EPS (TTM) – 2.17 Dividend Yield (%) – 0.39% Face Value (Rs) - 1 Share Holding Pattern Financial Details
  • 4. Industry Forecast Global chemical market size was estimated at USD 3.9 trillion in 2013 and is expected to grow at 3-4% per annum over the next 5 years to reach USD 4.7 trillion by 2018. India currently accounts for approximately 3% of the world chemical market. The Indian chemical and petrochemical industry expanded in 2013 despite weakness in key export markets and subdued growth in the domestic market. The Indian chemical and petrochemical industry currently stands at USD 118 Bn and is expected to grow at a CAGR of 8% for the next five years. The share of this sector in the manufacturing GDP was 15% during 2012-13 and it accounted for ~9% of the total India's exports. Bulk chemicals form the largest sub-segment of Indian chemical industry with 40% market share whereas specialty chemicals with ~19% market share is the fastest growing segment. The current low per capita consumption across industries and segments and strong growth outlook for the key end use are the key growth drivers for this industry. To meet the increasing demand either the local production will have to ramp up or it will be met by imports. In the past decade, India didn't tap its manufacturing potential to the fullest which led to a surge in the chemical imports. Net imports have grown at ~20% between FY09 and FY13 where in the same period the domestic output has grown by ~4%.However, going forward, 'Made in India' could become the next big manufacturing growth story. The Government has set an ambitious plan of increasing the share of manufacturing in GDP from 16% to 25% by 2022. Driven by the strong growth outlook for end use industries, the domestic market for specialty chemicals is expected to grow strongly, buoyed also by the increased adoption of specialty chemicals and their increased usage in different products categories. Paints coating and construction chemicals, colorants, Active Pharmaceutical Ingredients (APIs), personal care chemicals and flavors & fragrances are the specific segments that are expected to do well in the Indian market.
  • 5. Balance Sheet Mar '14 Mar '13 Mar '12 Mar '11 Mar '10 Sources Of Funds Total Share Capital 9.44 9.39 9.36 9.31 5.81 Equity Share Capital 9.44 9.39 9.36 9.31 5.81 Reserves 67.03 51.51 39.89 32.19 27.49 Networth 76.47 60.90 49.25 41.50 33.30 Secured Loans 114.29 91.84 76.69 63.91 40.37 Unsecured Loans 0.00 6.95 6.97 4.31 0.00 Total Debt 114.29 98.79 83.66 68.22 40.37 Total Liabilities 190.76 159.69 132.91 109.72 73.67 Mar '14 Mar '13 Mar '12 Mar '11 Mar '10 Application Of Funds Gross Block 90.45 92.85 81.69 69.41 60.46 Less: Accum. Depreciation 42.55 38.67 33.27 29.47 23.24 Net Block 47.90 54.18 48.42 39.94 37.22 Capital Work in Progress 2.00 0.76 2.23 3.50 2.07 Investments 3.81 1.33 1.33 1.48 3.40 Inventories 48.84 88.68 48.46 28.98 22.53 Sundry Debtors 91.49 68.48 62.80 40.25 32.96 Cash and Bank Balance 14.37 10.37 7.08 1.42 0.33 Total Current Assets 154.70 167.53 118.34 70.65 55.82 Loans and Advances 78.87 35.97 40.64 35.22 9.65 Fixed Deposits 0.00 0.00 0.00 3.53 2.59 Total CA, Loans & Advances 233.57 203.50 158.98 109.40 68.06 Current Liabilities 86.83 91.66 72.99 40.60 34.25 Provisions 9.69 8.43 5.06 4.01 2.82 Total CL & Provisions 96.52 100.09 78.05 44.61 37.07 Net Current Assets 137.05 103.41 80.93 64.79 30.99 Miscellaneous Expenses 0.00 0.00 0.00 0.00 0.00 Total Assets 190.76 159.68 132.91 109.71 73.68 Contingent Liabilities 145.74 104.86 60.24 29.95 24.24 Book Value (Rs) 16.20 12.97 10.52 44.59 57.28
  • 6. Profit and Loss Account Mar '14 Mar '13 Mar '12 Mar '11 Mar '10 Income Sales Turnover 374.39 313.53 252.06 166.76 126.99 Excise Duty 0.00 0.00 0.00 2.09 2.58 Net Sales 374.39 313.53 252.06 164.67 124.41 Other Income 2.33 2.87 3.56 1.40 1.85 Stock Adjustments -6.27 0.85 5.67 6.03 -1.91 Total Income 370.45 317.25 261.29 172.10 124.35 Expenditure Raw Materials 231.52 202.38 171.46 113.01 73.44 Power & Fuel Cost 10.40 10.20 10.68 8.71 9.05 Employee Cost 13.98 11.28 9.45 8.11 6.46 Other Manufacturing Expenses 0.00 0.00 0.00 6.13 3.79 Selling and Admin Expenses 0.00 0.00 0.00 12.83 10.64 Miscellaneous Expenses 53.62 44.78 30.56 3.58 3.94 Total Expenses 309.52 268.64 222.15 150.20 107.32 Operating Profit 58.60 45.74 35.58 20.50 15.18 PBDIT 60.93 48.61 39.14 21.90 17.03 Interest 22.40 17.52 16.20 8.00 6.04 PBDT 38.53 31.09 22.94 13.90 10.99 Depreciation 9.32 8.56 6.49 5.46 4.43 Profit Before Tax 29.21 22.53 16.45 8.44 6.56 PBT (Post Extra-ord Items) 29.21 22.53 16.45 8.44 6.56 Tax 10.24 7.77 6.30 1.76 2.30 Reported Net Profit 18.97 14.76 10.14 6.66 4.29 Total Value Addition 78.00 66.26 50.70 37.21 33.87 Equity Dividend 3.32 2.82 2.34 1.86 1.16 Corporate Dividend Tax 0.56 0.48 0.38 0.30 0.20 Per share data (annualised) Shares in issue (lakhs) 472.04 469.44 467.94 93.06 58.14 Earning Per Share (Rs) 4.02 3.14 2.17 7.16 7.37 Equity Dividend (%) 35.00 30.00 25.00 20.00 20.00
  • 8. Index and Company Price Movement Comparison
  • 9. Symbol Value Action RSI(14) 50.125 Neutral STOCH(9,6) 79.583 Buy STOCHRSI(14) 90.436 Overbought MACD(12,26) -0.130 Sell ADX(14) 25.986 Buy Williams %R -5.000 Overbought CCI(14) 50.8656 Buy ATR(14) 0.3679 Less Volatility Highs/Lows(14) 0.0929 Buy Ultimate Oscillator 55.992 Buy ROC -0.386 Sell Bull/Bear Power(13) 0.3140 Buy Technical Indicators
  • 10. PBIT – 13.07 v/s 11.75 RoCE – 27.04 v/s 25.07 RoE – 36.19 v/s 25.52 Net Profit Margin – 5.03 v/s 4.66 Return on net worth – 24.80 v/s 24.23 D/ E Ratio – 1.49 v/s 1.62 Interest Cover – 2.30 v/s 2.29 Current Ratio – 0.87 v/s 0.92 Reserves – 67.03 cr v/s 51.51 cr PAT – 18.97 cr v/s 14.76 cr Total assets – 190.76 cr v/s 159.08 cr Net sales – 374.39 cr v/s 313.53 cr Book Value – 16.20 v/s 12.97 Important Ratios Days BSE 30 87.15 50 80.03 150 65.29 200 58.31 Simple Moving Average
  • 11. Recommendations Buy Camlin Fine Sciences Ltd. at current or lower market levels Reasons for the recommendations are : Healthy financial position and attractive ratios. Very less competition for the company products. Increase in demands for junk foods, pharma products and cosmetics will increase in revenue of the company. Good performance by company owned subsidiaries will increase profits. Growth forecast of the this sector of the industry. Attractive CAGR of the company in recent years.